Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Savvy Investors Bet Millions On Royalty-Fueled Pharma Stock
Placement on two elite stock screens and promising technical indicators put Ligand Pharmaceuticals (LGND) in focus. Ligand stock has landed a spot on the IBD 50 and the latest list of new buys by the best mutual funds. The monthly screen showed…
Swiss pharma group warns medicine access is worsening
A survey of member companies has shown that pharmaceutical manufacturers no longer consider themselves able, under the current framework, to launch new therapies in Switzerland in a timely manner without jeopardising prices in the US, Interpharma…
India's Q1 pharma exports up 6.8% to $8.1bn; U.S. remains largest export destination
India's pharmaceutical exports rose 6.8% year-on-year (YoY) to $8.1 billion in the first quarter (Q1) ended June, according to the Pharmaceuticals Export Promotion Council of India (Pharmexcil). Drug formulations and biologicals exports stood at…
Wave Life Sciences: A $1 Billion RNA-Medicine Bargain Ripe for Pharma Takeover
WVE sits 69% below its yearly high at a $1 billion market cap, with obesity drug WVE-007 showing visceral fat cuts and muscle preservation. GSK leads plausible acquirers given its existing WVE-006 partnership, while LLY could attach WVE-007 to…
Ascendis Pharma A/S Q2 Earnings Call Highlights
Can BioMarin Stock Live Up to Wall Street's High Expectations? Ascendis Pharma A/ S NASDAQ: ASND reported second-quarter 2026 total revenue of EUR 339 million, including EUR 315 million in product revenue, as demand for its three commercial…
Haypp Group, Terravest Industries, Zedcor Inc, Delcath, and Moberg Pharma report
When Haypp Group decides to prioritize earnings instead of growth, they will make a lot of money. They are obviously still trying to grow as fast as they can. Ironically if they stay in this growth state forever the shares would probably continue…
Kyverna Therapeutics: Market Holding Flat Despite Progress To Approval (NASDAQ:KYTX)
Kyverna Therapeutics, Inc. remains a compelling Buy as it advances mivocabtagene autoleucel for autoimmune diseases, targeting first approval in stiff person syndrome. Updated KYSA-8 trial data show all 26 patients remained off chronic…
Is the Reported $400 Billion AstraZeneca-Bristol Myers Squibb Megamerger a Slam Dunk -- or a Disaster Waiting to Happen?
In recent weeks, two pharmaceutical stocks, AstraZeneca (AZN -0.80%) and Bristol Myers Squibb (BMY +1.49%), have become the subject of merger rumors. At the start of the month, the Financial Times dropped a potential bombshell when, in an exclusive…
Doximity (DOCS) Q1 2027 Earnings Call Transcript
Thursday, Aug. 6, 2026 at 5:00 p.m. ET Senior Vice President, Investor Relations - Perry Gold Co-Founder and CEO - Jeffrey Tangney CFO - Matthew Sonefeldt Revenue -- $156.6 million, up 7% year over year, driven by stable spending from large…
Impax International Sustainable Economy Fund Q2 2026 Contributors And Detractors
The portfolio outperformed the MSCI EAFE benchmark in the second quarter of 2026. Contributors include Infineon Technologies, Tokyo Electron and Recruit Holdings. Detractors include Murata Manufacturing, SoftBank Group and Astellas Pharma. The…
The Investment Company of America, AIVSX, Has Outlasted Nearly Every Fund Launched Beside It
Most mutual funds launched in the 1930s are footnotes in a finance textbook. The Investment Company of America (NASDAQ:AIVSX) is still open, still paying dividends, and still one of the largest actively managed U.S. equity funds on the planet. Its…
Medicare Part D: The cost of ending drug subsidies
Millions of older Americans who are already struggling with rising gas and food prices will soon have to pay more for prescription drugs, said Anna Wilde Mathews in The Wall Street Journal. The Trump administration announced last week that it is…
Josh Brown says this stock on his list is worth stalking for a big move higher
(This is The Best Stocks in the Market, brought to you by Josh Brown and Sean Russo of Ritholtz Wealth Management.) Josh — This is the story of a 73-year old company that's had a wild, transatlantic ride from its beginnings as a plumbing…
Anthony Fauci And The Collapse Of Scientific Authority
Today's guest essay comes from Jason Locasale who looks at academia's embrace of authority over scientific data and evidence to preserve narratives and protect those in power. Anthony Fauci is now facing intense scrutiny. His diaries, emails, and…
Cryoport (CYRX) Q2 2026 Earnings Call Transcript
Thursday, Aug. 6, 2026 at 5 p.m. ET Chief Executive Officer - Jerrell Shelton Executive Vice President and Chief Financial Officer - Robert Stefanovich Chief Scientific Officer - Mark Sawicki Vice President of Corporate Development and Investor…
Receive a Daily briefing on Pharma Industry News
Get Started